Metraipolis › archive › dc_e2a61037cf36

Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis — Europe PMC PMID:40971670

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40971670
DOI
10.1093/rheumatology/keaf490
License (as archived)
solo-consultazione
Archived
2026-10-08T05:35:03.764Z
SHA-256 of the archived text
4d14741bcfefe8dc596d226026b0557770e046834337794dc41b00add0f50d50
Stable URL of this page
https://metraipolis.com/documento/dc_e2a61037cf36

How to cite

Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis — Europe PMC PMID:40971670 — Europe PMC (en), https://europepmc.org/article/MED/40971670 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2a61037cf36 (Metraipolis archive dc_e2a61037cf36, sha256 4d14741bcfefe8dc596d226026b0557770e046834337794dc41b00add0f50d50)
BibTeX
@misc{dce2a61037cf36,
  title = {Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis — Europe PMC PMID:40971670},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40971670},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2a61037cf36; sha256 4d14741bcfefe8dc596d226026b0557770e046834337794dc41b00add0f50d50},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40971670. Agents can read the archived copy with the MCP tool read_document.